Biological Sciences and Healthcare, part 3

... > Body structure > Morphologically altered structure > Morphologic abnormality > Growth alteration > Proliferation > Proliferative mass (morphologic abnormality) > Neoplasm and/or hamartoma (morphologic abnormality) > Tumor > Malignant Neoplasm (Morphology) > Malignant hematopoietic neoplasm (morphologic abnormality) > leukaemia > Acute leukemia > Acute mixed lineage leukaemia > Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)

... > Body structure > Morphologically altered structure > Morphologic abnormality > Lesion, NOS > Mass > Proliferative mass (morphologic abnormality) > Neoplasm and/or hamartoma (morphologic abnormality) > Tumor > Malignant Neoplasm (Morphology) > Malignant hematopoietic neoplasm (morphologic abnormality) > leukaemia > Acute leukemia > Acute mixed lineage leukaemia > Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)

... > Body structure > Morphologically altered structure > Morphologic abnormality > Growth alteration > Proliferation > Proliferative mass (morphologic abnormality) > Neoplasm and/or hamartoma (morphologic abnormality) > Tumor > Hematopoietic neoplasm (morphologic abnormality) > Malignant hematopoietic neoplasm (morphologic abnormality) > leukaemia > Acute leukemia > Acute mixed lineage leukaemia > Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)

... > Body structure > Morphologically altered structure > Morphologic abnormality > Lesion, NOS > Mass > Proliferative mass (morphologic abnormality) > Neoplasm and/or hamartoma (morphologic abnormality) > Tumor > Hematopoietic neoplasm (morphologic abnormality) > Malignant hematopoietic neoplasm (morphologic abnormality) > leukaemia > Acute leukemia > Acute mixed lineage leukaemia > Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 (morphologic abnormality)